Floatz logo

Therapeutic Asset Ratings

4,361 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Veliparib
Ovarian Carcinoma
National Cancer Institute (NCI)P2BB (66)
Veliparib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2BB (66)
Venetoclax
Refractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)P2BB (66)
(+)-VINCRISTINE
Ovarian Carcinosarcoma
National Cancer Institute (NCI)P2BB (66)
Ziv-Aflibercept
Melanoma
National Cancer Institute (NCI)P2BB (66)
Cediranib
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P2/3BB (66)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)P2/3BB (66)
Hycamtin
Ovarian Seromucinous Carcinoma
National Cancer Institute (NCI)P2/3BB (66)
Hycamtin
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)P2/3BB (66)
Inno-206
Primary Peritoneal Serous Adenocarcinoma
National Cancer Institute (NCI)P2/3BB (66)
Dabrafenib
Anaplastic Ganglioglioma
National Cancer Institute (NCI)P4BB (65)
Dabrafenib
Anaplastic Pleomorphic Xanthoastrocytoma
National Cancer Institute (NCI)P4BB (65)
gsk1120212
Anaplastic Astrocytoma
National Cancer Institute (NCI)P4BB (65)
Ribociclib
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)P4BB (65)
Azacitidine
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)P3BB (65)
DEXAMETHASONE
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P3BB (65)
Docetaxel
Ovarian Brenner Tumor
National Cancer Institute (NCI)P3BB (65)
Docetaxel
Ovarian Seromucinous Carcinoma
National Cancer Institute (NCI)P3BB (65)
Docetaxel
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)P3BB (65)
Epirubicin
Classic Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (65)
Inno-206
Lymphoplasmacytic Lymphoma
National Cancer Institute (NCI)P3BB (65)
Nivolumab
Classic Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (65)
Nivolumab
Classic Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (65)
Pembrolizumab
Classic Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (65)
PREDNISONE TABLETS
Lymphoplasmacytic Lymphoma
National Cancer Institute (NCI)P3BB (65)
Showing 351 to 375 of 4,361 assets
PreviousPage 15 of 175Next